Penicillin Production from Transformed Protoplast of Penicillium chrysogenum by Fermentation

M. Sukumar, M. Sundar, M. Sivarajan
{"title":"Penicillin Production from Transformed Protoplast of Penicillium chrysogenum by Fermentation","authors":"M. Sukumar, M. Sundar, M. Sivarajan","doi":"10.4172/2153-0645.1000102","DOIUrl":null,"url":null,"abstract":"The Protoplast was prepared from the Penicillium chrysogenum and confirmed by microscopic observation and strains from the Penicillium chrysogenum were intrafused and protoplast was regenerated. The Penicillin was produced by fermentation method. The DNA was isolated from the Sclerotium rolfsii and it was characterized by electrophoresis and Protoplast of Penicillium chrysogenum was transformed with DNA of Sclerotium rolfsii. Penicillin was produced from transformed protoplast of Penicillium chrysogenum and at last HPLC was used to quantify the penicillin. Penicil - lin was isolated and purified and injected into experimental animals, where it was found not only to cure infections but also to possess incredibly low toxicity for the animals. This fact ushered into being the age of antibiotic chemotherapy, and an intense search for similar antimicrobial agents of low toxicity to animals that might prove useful in the treatment of infectious disease. Penicillium and Cephalosporium molds produce beta-lactam antibiotics such as penicillin and cephalosporin and their relatives. They also produce the base molecule for development of semisynthetic beta-lactam antibiotics, such as amoxacillin and ampicillin. Beta-lactams are used to treat about one-third of outpatients with bacte - rial infections.","PeriodicalId":333396,"journal":{"name":"Journal of Pharmacogenomics and Pharmacoproteomics","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacogenomics and Pharmacoproteomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2153-0645.1000102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

The Protoplast was prepared from the Penicillium chrysogenum and confirmed by microscopic observation and strains from the Penicillium chrysogenum were intrafused and protoplast was regenerated. The Penicillin was produced by fermentation method. The DNA was isolated from the Sclerotium rolfsii and it was characterized by electrophoresis and Protoplast of Penicillium chrysogenum was transformed with DNA of Sclerotium rolfsii. Penicillin was produced from transformed protoplast of Penicillium chrysogenum and at last HPLC was used to quantify the penicillin. Penicil - lin was isolated and purified and injected into experimental animals, where it was found not only to cure infections but also to possess incredibly low toxicity for the animals. This fact ushered into being the age of antibiotic chemotherapy, and an intense search for similar antimicrobial agents of low toxicity to animals that might prove useful in the treatment of infectious disease. Penicillium and Cephalosporium molds produce beta-lactam antibiotics such as penicillin and cephalosporin and their relatives. They also produce the base molecule for development of semisynthetic beta-lactam antibiotics, such as amoxacillin and ampicillin. Beta-lactams are used to treat about one-third of outpatients with bacte - rial infections.
由青霉菌原生质体转化发酵生产青霉素
以青霉菌为原料制备原生质体,经显微观察证实,并注入该菌种进行原生质体再生。青霉素是用发酵法生产的。从罗尔夫菌核中分离出DNA,对其进行电泳鉴定,并利用罗尔夫菌核DNA转化青霉菌原生质体。盘尼西林是由青霉菌的原生质体转化而来,最后用高效液相色谱法对盘尼西林进行定量分析。青霉素被分离纯化并注射到实验动物中,在实验中发现它不仅可以治疗感染,而且对动物具有令人难以置信的低毒性。这一事实开启了抗生素化疗的时代,人们开始强烈寻找对动物低毒性的类似抗菌剂,这些抗菌剂可能被证明对治疗传染病有用。青霉菌和头孢菌霉菌产生β -内酰胺类抗生素,如青霉素和头孢菌素及其亲戚。它们还生产用于开发半合成-内酰胺类抗生素的基本分子,如阿莫西林和氨苄西林。β -内酰胺类药物用于治疗大约三分之一的门诊细菌感染患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信